Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

References for PMC Articles for PubMed (Select 21632892)

1.

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older.

Meijer CJ, Berkhof J, Castle PE, Hesselink AT, Franco EL, Ronco G, Arbyn M, Bosch FX, Cuzick J, Dillner J, Heideman DA, Snijders PJ.

Int J Cancer. 2009 Feb 1;124(3):516-20. doi: 10.1002/ijc.24010.

2.

Human papillomavirus genotype specificity of hybrid capture 2.

Castle PE, Solomon D, Wheeler CM, Gravitt PE, Wacholder S, Schiffman M.

J Clin Microbiol. 2008 Aug;46(8):2595-604. doi: 10.1128/JCM.00824-08. Epub 2008 Jun 25.

4.

2006 consensus guidelines for the management of women with abnormal cervical screening tests.

Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D; 2006 ASCCP-Sponsored Consensus Conference.

J Low Genit Tract Dis. 2007 Oct;11(4):201-22. Erratum in: J Low Genit Tract Dis. 2008 Jul;12(3):255.

PMID:
17917566
5.

The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assays.

Stoler MH, Castle PE, Solomon D, Schiffman M; American Society for Colposcopy and Cervical Pathology.

Am J Clin Pathol. 2007 Mar;127(3):335-7. No abstract available.

6.
7.

The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.

Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M.

J Natl Cancer Inst. 2005 Jul 20;97(14):1072-9.

8.

A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations.

ASCUS-LSIL Traige Study (ALTS) Group.

Am J Obstet Gynecol. 2003 Jun;188(6):1393-400.

PMID:
12824968
9.
10.

American Cancer Society guideline for the early detection of cervical neoplasia and cancer.

Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, Cohen C; American Cancer Society.

CA Cancer J Clin. 2002 Nov-Dec;52(6):342-62. Review.

PMID:
12469763
11.

The 2001 Bethesda System: terminology for reporting results of cervical cytology.

Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr, Young N; Forum Group Members; Bethesda 2001 Workshop.

JAMA. 2002 Apr 24;287(16):2114-9. Review.

PMID:
11966386
12.

Determinants of genital human papillomavirus detection in a US population.

Peyton CL, Gravitt PE, Hunt WC, Hundley RS, Zhao M, Apple RJ, Wheeler CM.

J Infect Dis. 2001 Jun 1;183(11):1554-64. Epub 2001 May 9.

13.
14.

ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants.

Schiffman M, Adrianza ME.

Acta Cytol. 2000 Sep-Oct;44(5):726-42.

PMID:
11015972
16.

Improved amplification of genital human papillomaviruses.

Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlée F, Hildesheim A, Schiffman MH, Scott DR, Apple RJ.

J Clin Microbiol. 2000 Jan;38(1):357-61.

17.

From Papanicolaou to Bethesda: the rationale for a new cervical cytologic classification.

Kurman RJ, Malkasian GD Jr, Sedlis A, Solomon D.

Obstet Gynecol. 1991 May;77(5):779-82.

PMID:
1849626
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk